Xenon in Sub-Anesthetic Doses for Treatment of Major Depression: A Proof-of-Concept Placebo-Controlled Pilot Study

Lyubomir Aftanas, Olga Akhmetova, Ivan Brack, Konstantin Danilenko, Alexander Khabarov, Ekaterina Nikolenko

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S319-S320
Number of pages2
JournalBiological Psychiatry
Issue number10
Publication statusPublished - 15 May 2017
Event72nd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP) - San Diego, Canada
Duration: 18 May 201720 May 2017


  • Major Depressive Disorder (MDD)
  • Xenon
  • NMDA antagonists
  • Novel treatments

Cite this